EVP

EVP, formerly known as Equity Venture Partners, is a Sydney-based early-stage venture firm with a disciplined focus on B2B SaaS, including the kind of mission-critical workflow and compliance software that underpins regulated enterprise verticals. Within healthcare, the firm targets health IT and broader vertical SaaS rather than therapeutics or device innovation, prioritizing software businesses where customer retention and contract economics drive durable value. The team has built a reputation for backing unglamorous infrastructure software where margins compound over time. Limited public information confirms specific named partners and the most recent portfolio additions on the team’s healthcare deals, so founders should validate fit through direct conversation.

Check sizes typically range from 1 million to 5 million dollars at seed and Series A, sized to support meaningful product investment and initial sales hires. Geography centers on Australia and New Zealand, with Sydney as the operating base, though the firm has historically been open to founders building globally from the region. EVP’s thesis discipline means founders working on consumer apps, hardware, or pre-product ideas will not find a natural home here.

The approach is metrics-driven and patient: the team is known for engaging deeply on go-to-market mechanics, sales hiring sequences, and the long arc of category creation in B2B SaaS. Founders who value an investor that asks pointed questions about ICP, churn, and CAC payback rather than vanity growth will respond well. Those who want lighter governance or rapid markups before durable revenue should look elsewhere. Initial conversations should center on commercial traction, the realism of the GTM plan, and how EVP has supported similar B2B SaaS portfolio companies through the Series A to B transition.